| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $215.5M | +20.2% |
| SG&A Expense | $50.1M | +0.7% |
| Operating Income | -$263.5M | -15.6% |
| Pre-tax Income | -$245.7M | -11.1% |
| Income Tax | $678K | — |
| Net Income | -$246.4M | -11.4% |
| EPS (Basic) | -$4.71 | +11.5% |
| EPS (Diluted) | -$4.71 | +11.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $112.5M | -7.2% |
| Current Assets | $347.6M | -20.7% |
| Total Assets | $423.4M | -17.5% |
| Current Liabilities | $42.5M | -4.9% |
| Total Liabilities | $220.2M | -2.7% |
| Stockholders' Equity | $203.2M | -29.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$192.2M | -3184.3% |
| Capital Expenditures | $12.4M | +21.3% |
| Investing Cash Flow | $68.4M | +130.3% |
| Financing Cash Flow | $115.1M | -47.5% |
| Free Cash Flow | -$204.6M | -1174.1% |